Florida Senate - 2026                        COMMITTEE AMENDMENT
       Bill No. SB 1758
       
       
       
       
       
       
                                Ì838908OÎ838908                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  02/02/2026           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Gaetz) recommended the
       following:
       
    1         Senate Amendment 
    2  
    3         Delete lines 457 - 461
    4  and insert:
    5  administered drug list, preferred product list, or high-cost
    6  drug list. Such public testimony must shall occur before prior
    7  to any recommendations made by the committee for inclusion or
    8  exclusion from the preferred drug list, preferred physician
    9  administered drug list, preferred product list, or high-cost
   10  drug list. Upon timely notice, the agency shall